SuperworthXenetic Biosciences shares outstanding XBIO
Diluted shares outstanding, averaged over each quarter, from 2011.
- Latest quarter, to Jun 30, 2026
- 2.3M
- On a year earlier
- +48.8%
- more shares
Xenetic Biosciences had 2.3M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 48.8% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 2.2M | +41% |
| FY2024 | 1.5M | +0% |
| FY2023 | 1.5M | +2% |
| FY2022 | 1.5M | +12% |
| FY2021 | 1.3M | +99% |
| FY2020 | 674.9K | +17% |
| FY2019 | 579.2K | +639% |
| FY2018 | 78.4K | +8% |
| FY2017 | 72.6K | +5% |
| FY2016 | 69.3K | +97% |
| FY2015 | 35.2K | +0% |
| FY2014 | 35.2K | +16% |
| FY2013 | 30.3K | +788% |
| FY2012 | 3.4K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 2.3M | +49% | |
| Q1 FY26 | 2.3M | +49% | |
| Q4 FY25 | 2.2M | +41% | |
| Q3 FY25 | 1.5M | +0% | |
| Q2 FY25 | 1.5M | +0% | |
| Q1 FY25 | 1.5M | +0% | |
| Q4 FY24 | 1.5M | +0% | |
| Q3 FY24 | 1.5M | +1% | |
| Q2 FY24 | 1.5M | +1% | |
| Q1 FY24 | 1.5M | +2% | |
| Q4 FY23 | 1.5M | +2% | |
| Q3 FY23 | 1.5M | +7% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Xenetic Biosciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.